Jesper Johannesen
Overview
Explore the profile of Jesper Johannesen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
491
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mynarek I, Krogvold L, Mork F, Lawaetz T, Roald T, Fagerland M, et al.
Diabetes Care
. 2025 Jan;
48(3):481-488.
PMID: 39804800
Objective: In the Diabetes Virus Detection and Intervention trial, antiviral treatment with pleconaril and ribavirin decreased the decline, compared with placebo, in endogenous C-peptide 1 year after diagnosis of type...
2.
3.
Jespersen L, Mikkelsen K, Frederiksen S, Johannesen J, Grabowski D
Patient Educ Couns
. 2024 Dec;
132():108579.
PMID: 39689633
Objective: The onset of childhood diabetes necessitates that the child and family quickly must learn numerous self-management tasks. Diabetes education is key to successful self-management, and established diabetes-related habits are...
4.
Hostrup P, Schmidt T, Hellsten S, Gerwig R, Storling J, Johannesen J, et al.
Diabetologia
. 2024 Oct;
68(1):29-40.
PMID: 39477880
Aims/hypothesis: Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, shows some promise in alleviating beta cell stress and preserving beta cell function in preclinical studies of type 1 diabetes. The aim...
5.
Damm J, Dalgas-Madsen A, Hansen C, Pilgaard K, Pociot F, Hansen T, et al.
J Diabetes Complications
. 2024 Sep;
38(11):108873.
PMID: 39306874
Aims: To investigate the prevalence of diabetic polyneuropathy (DPN), cardiac autonomic neuropathy (CAN) and sudomotor dysfunction in children and adolescents with type 1 diabetes using bedside modalities. Secondly, to evaluate...
6.
Greve J, Mork F, Jensen A, Kaur S, Madsen J, Bugge A, et al.
Scand J Clin Lab Invest
. 2024 Jul;
84(4):285-295.
PMID: 39012082
It is internationally recognized to use clinical decision limits (CDL) when interpreting the lipid levels in both adults and children, even though the evidence for children is scarce. The purpose...
7.
Torm M, Pircher M, Bonnin S, Johannesen J, Klefter O, Schmidt M, et al.
Sci Rep
. 2024 Jun;
14(1):13450.
PMID: 38862584
This study tested if a high-resolution, multi-modal, multi-scale retinal imaging instrument can provide novel information about structural abnormalities in vivo. The study examined 11 patients with very mild to moderate...
8.
Marcovecchio M, Hendriks A, Delfin C, Battelino T, Danne T, Evans M, et al.
Diabetologia
. 2024 Mar;
67(6):995-1008.
PMID: 38517484
Aims/hypothesis: Type 1 diabetes is an heterogenous condition. Characterising factors explaining differences in an individual's clinical course and treatment response will have important clinical and research implications. Our aim was...
9.
Krogvold L, Mynarek I, Ponzi E, Mork F, Hessel T, Roald T, et al.
Nat Med
. 2023 Oct;
29(11):2902-2908.
PMID: 37789144
Previous studies showed a low-grade enterovirus infection in the pancreatic islets of patients with newly diagnosed type 1 diabetes (T1D). In the Diabetes Virus Detection (DiViD) Intervention, a phase 2,...
10.
Bering L, Christensen A, Birk N, Thygesen L, Bundgaard H, Benfield T, et al.
Pediatr Infect Dis J
. 2023 Aug;
42(11):999-1001.
PMID: 37566892
We investigated the association between SARS-CoV-2 infection and new-onset type 1 diabetes (T1D) in children and adolescents in a nationwide, matched cohort study. The hazard ratio of new-onset T1D within...